In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C raises $20mm for eye device start-up NovaVision

Executive Summary

NovaVision (devices that help restore vision after neurological injury) grossed $20mm through a Series C financing that was led by new buyer Chicago Growth Partners and included fellow first-time investors J&J Development Corp. and Oakwood Medical Investors, plus returning backers Tullis-Dickerson, Noro-Moseley Partners, and Crossbow Ventures.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies